show that MyD88 in myofibroblasts can promote hepatocarcinogenesis associated with non‐alcoholic fatty liver disease (NAFLD) by enhancing M2 polarization of macrophages [31]. Here, MYD88 is linked to metabolic dysfunction-associated steatotic liver disease.